Bios Fund III Overview
Bios Fund III General Information
Description
Bios Fund III is a venture capital fund managed by Bios Partners. The fund is located in Fort Worth, Texas. The find invests in sector of healthcare device, supply, pharmaceutical and biotechnology.
Contact Information
Fund Manager's Location
- 1751 River Run
- Suite 400
- Fort Worth, TX 76107
- United States
Bios Fund III Investments (1)
Bios Fund III has made one investment. Its deal was a Early Stage VC (Series B) with Taysha Gene Therapies for , made on 05-Aug-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Taysha Gene Therapies | 05-Aug-2020 | Early Stage VC (Series B) | Drug Discovery | Startup |
Bios Fund III Investment Strategy
Investments by Industry
Investments by Deal Type
Bios Fund III Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Bios Fund III Benchmark (711)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Developer Integration Fund | |||||
| TIFIN Capital Partners Fund | |||||
| Vestigo Ventures Fund II | |||||
| SpaceFund One | |||||
| Curative Ventures V | |||||
| IV Lonestar | 31-Mar-2025 | ||||
| Patamar Fund II | |||||
| LRI Vision Partners Fund II | |||||
| R3 Development Fund | |||||
| Yield Lab Global Opportunity Fund |
Bios Fund III FAQs
-
What is Bios Fund III?
Bios Fund III is a venture capital fund managed by Bios Partners.
-
Who manages Bios Fund III?
Bios Fund III is managed by Bios Partners.
-
Where is Bios Fund III domiciled?
Bios Fund III is domiciled in United States: Delaware.
-
What is Bios Fund III's size?
Bios Fund III has a size of .
-
What type of fund is Bios Fund III?
The fund type of Bios Fund III is Venture.
-
What is the status of Bios Fund III?
Bios Fund III is closed.
-
What has Bios Fund III invested in?
Bios Fund III has invested in Taysha Gene Therapies within the Drug Discovery industry.
-
What has Bios Fund III invested in recently?
Bios Fund III's latest investment was on 05-Aug-2020 in Taysha Gene Therapies, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
